Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −66,403−100.0% | Sold out | Holders |
| Q3 2024 | 66,403 | $1.28M | <0.1% | +110+0.2% | Added | Holders |
| Q2 2024 | 66,293 | $1.36M | <0.1% | +6,369+10.6% | Added | Holders |
| Q1 2024 | 59,924 | $1.43M | <0.1% | +11,798+24.5% | Added | Holders |
| Q4 2023 | 48,126 | $1.04M | <0.1% | −3,110−6.1% | Reduced | Holders |
| Q3 2023 | 51,236 | $743.9K | <0.1% | +651+1.3% | Added | Holders |
| Q2 2023 | 50,585 | $1.06M | <0.1% | +5,496+12.2% | Added | Holders |
| Q1 2023 | 45,089 | $952.3K | <0.1% | −317−0.7% | Reduced | Holders |
| Q4 2022 | 45,406 | $1.16M | <0.1% | +14,554+47.2% | Added | Holders |
| Q3 2022 | 30,852 | $741.0K | <0.1% | −2,504−7.5% | Reduced | Holders |
| Q2 2022 | 33,356 | $642.0K | <0.1% | −23,180−41.0% | Reduced | Holders |
| Q1 2022 | 56,536 | $983.0K | <0.1% | −1,643−2.8% | Reduced | Holders |
| Q4 2021 | 58,179 | $1.27M | <0.1% | −1,414−2.4% | Reduced | Holders |
| Q3 2021 | 59,593 | $1.14M | <0.1% | −3,948−6.2% | Reduced | Holders |
| Q2 2021 | 63,541 | $1.09M | <0.1% | +63,541 | New | Holders |